These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


243 related items for PubMed ID: 17635180

  • 1. Determination of ABCB1 polymorphisms and haplotypes frequencies in a French population.
    Jeannesson E, Albertini L, Siest G, Gomes AM, Ribeiro V, Aslanidis C, Schmitz G, Visvikis-Siest S.
    Fundam Clin Pharmacol; 2007 Aug; 21(4):411-8. PubMed ID: 17635180
    [Abstract] [Full Text] [Related]

  • 2. Association of ABCB1 gene polymorphisms with plasma lipid and apolipoprotein concentrations in the STANISLAS cohort.
    Jeannesson E, Siest G, Bastien B, Albertini L, Aslanidis C, Schmitz G, Visvikis-Siest S.
    Clin Chim Acta; 2009 May; 403(1-2):198-202. PubMed ID: 19285054
    [Abstract] [Full Text] [Related]

  • 3. A variant 2677A allele of the MDR1 gene affects fexofenadine disposition.
    Yi SY, Hong KS, Lim HS, Chung JY, Oh DS, Kim JR, Jung HR, Cho JY, Yu KS, Jang IJ, Shin SG.
    Clin Pharmacol Ther; 2004 Nov; 76(5):418-27. PubMed ID: 15536457
    [Abstract] [Full Text] [Related]

  • 4. Relationship between the C3435T and G2677T(A) polymorphisms in the ABCB1 gene and P-glycoprotein expression in human liver.
    Owen A, Goldring C, Morgan P, Chadwick D, Park BK, Pirmohamed M.
    Br J Clin Pharmacol; 2005 Mar; 59(3):365-70. PubMed ID: 15752383
    [Abstract] [Full Text] [Related]

  • 5. Genotype and allele frequencies of MDR1 gene C1236T polymorphism in a Turkish population.
    Gümüş-Akay G, Rüstemoğlu A, Karadağ A, Sunguroğlu A.
    Genet Mol Res; 2008 Oct 28; 7(4):1193-9. PubMed ID: 19048498
    [Abstract] [Full Text] [Related]

  • 6. ABCB1 gene polymorphisms are not associated with treatment outcome in elderly acute myeloid leukemia patients.
    van der Holt B, Van den Heuvel-Eibrink MM, Van Schaik RH, van der Heiden IP, Wiemer EA, Vossebeld PJ, Löwenberg B, Sonneveld P.
    Clin Pharmacol Ther; 2006 Nov 28; 80(5):427-39. PubMed ID: 17112800
    [Abstract] [Full Text] [Related]

  • 7. Adenosine triphosphate-binding cassette B1 (ABCB1) (multidrug resistance 1) G2677T/A gene polymorphism is associated with high risk of lung cancer.
    Gervasini G, Carrillo JA, Garcia M, San Jose C, Cabanillas A, Benitez J.
    Cancer; 2006 Dec 15; 107(12):2850-7. PubMed ID: 17120199
    [Abstract] [Full Text] [Related]

  • 8. ABCB1 genetic variability and methadone dosage requirements in opioid-dependent individuals.
    Coller JK, Barratt DT, Dahlen K, Loennechen MH, Somogyi AA.
    Clin Pharmacol Ther; 2006 Dec 15; 80(6):682-90. PubMed ID: 17178268
    [Abstract] [Full Text] [Related]

  • 9. ABCB1 polymorphisms influence the response to antiepileptic drugs in Japanese epilepsy patients.
    Seo T, Ishitsu T, Ueda N, Nakada N, Yurube K, Ueda K, Nakagawa K.
    Pharmacogenomics; 2006 Jun 15; 7(4):551-61. PubMed ID: 16753003
    [Abstract] [Full Text] [Related]

  • 10. Haplotype-based analysis of MDR1/ABCB1 gene polymorphisms in a Turkish population.
    Gümüş-Akay G, Rüstemoğlu A, Karadağ A, Sunguroğlu A.
    DNA Cell Biol; 2010 Feb 15; 29(2):83-90. PubMed ID: 20025534
    [Abstract] [Full Text] [Related]

  • 11. Common germline MDR1/ABCB1 functional polymorphisms and haplotypes modify susceptibility to colorectal cancers with high microsatellite instability.
    Potocnik U, Glavac D, Dean M.
    Cancer Genet Cytogenet; 2008 May 15; 183(1):28-34. PubMed ID: 18474294
    [Abstract] [Full Text] [Related]

  • 12. Single nucleotide polymorphisms in the multidrug resistance gene 1 (ABCB1): effects on its expression and clinicopathological characteristics in breast cancer patients.
    Vaclavikova R, Nordgard SH, Alnaes GI, Hubackova M, Kubala E, Kodet R, Mrhalova M, Novotny J, Gut I, Kristensen VN, Soucek P.
    Pharmacogenet Genomics; 2008 Mar 15; 18(3):263-73. PubMed ID: 18300948
    [Abstract] [Full Text] [Related]

  • 13. No association of ABCB1 polymorphisms with drug-refractory epilepsy in a north Indian population.
    Lakhan R, Misra UK, Kalita J, Pradhan S, Gogtay NJ, Singh MK, Mittal B.
    Epilepsy Behav; 2009 Jan 15; 14(1):78-82. PubMed ID: 18812236
    [Abstract] [Full Text] [Related]

  • 14. Multi-drug resistance-1 gene polymorphisms in nephrotic syndrome: impact on susceptibility and response to steroids.
    Youssef DM, Attia TA, El-Shal AS, Abduelometty FA.
    Gene; 2013 Nov 10; 530(2):201-7. PubMed ID: 23994685
    [Abstract] [Full Text] [Related]

  • 15. Genotyping of eight polymorphic genes encoding drug-metabolizing enzymes and transporters using a customized oligonucleotide array.
    Lu Y, Kham SK, Foo TC, Ariffin H, Quah TC, Yeoh AE.
    Anal Biochem; 2007 Jan 01; 360(1):105-13. PubMed ID: 17113562
    [Abstract] [Full Text] [Related]

  • 16. Triallelic single nucleotide polymorphisms and genotyping error in genetic epidemiology studies: MDR1 (ABCB1) G2677/T/A as an example.
    Hüebner C, Petermann I, Browning BL, Shelling AN, Ferguson LR.
    Cancer Epidemiol Biomarkers Prev; 2007 Jun 01; 16(6):1185-92. PubMed ID: 17548683
    [Abstract] [Full Text] [Related]

  • 17. Association between ABCB1 polymorphism and response to sodium valproate treatment in Malaysian epilepsy patients.
    Haerian BS, Lim KS, Tan HJ, Mohamed EH, Tan CT, Raymond AA, Wong CP, Wong SW, Omar H, Roslan H, Mohamed Z.
    Epileptic Disord; 2011 Mar 01; 13(1):65-75. PubMed ID: 21388909
    [Abstract] [Full Text] [Related]

  • 18. Common ATP-binding cassette B1 variants are associated with increased digoxin serum concentration.
    Aarnoudse AJ, Dieleman JP, Visser LE, Arp PP, van der Heiden IP, van Schaik RH, Molokhia M, Hofman A, Uitterlinden AG, Stricker BH.
    Pharmacogenet Genomics; 2008 Apr 01; 18(4):299-305. PubMed ID: 18334914
    [Abstract] [Full Text] [Related]

  • 19. Potential impact of ABCB1 (p-glycoprotein) polymorphisms on avermectin toxicity in humans.
    Macdonald N, Gledhill A.
    Arch Toxicol; 2007 Aug 01; 81(8):553-63. PubMed ID: 17354009
    [Abstract] [Full Text] [Related]

  • 20. Hepatic technetium Tc 99m-labeled sestamibi elimination rate and ABCB1 (MDR1) genotype as indicators of ABCB1 (P-glycoprotein) activity in patients with cancer.
    Wong M, Evans S, Rivory LP, Hoskins JM, Mann GJ, Farlow D, Clarke CL, Balleine RL, Gurney H.
    Clin Pharmacol Ther; 2005 Jan 01; 77(1):33-42. PubMed ID: 15637529
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 13.